Medline, Inc. (MDLN)
39.15
-0.32
(-0.81%)
USD |
NASDAQ |
Nov 16, 16:00
39.10
-0.05
(-0.13%)
After-Hours: 20:00
Medline EPS Diluted (Quarterly) : 0.2188 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.2188 |
| June 30, 2026 | 0.0697 |
| March 31, 2026 | 0.1564 |
| December 31, 2025 | 0.2241 |
| September 30, 2025 | 0.4026 |
| June 30, 2025 | 0.4164 |
| Date | Value |
|---|---|
| March 31, 2025 | 0.4026 |
| December 31, 2024 | 0.3613 |
| September 30, 2024 | 0.4051 |
| June 30, 2024 | 0.3651 |
| March 31, 2024 | 0.3688 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5294 |
| AngioDynamics, Inc. | -0.1689 |
| Alphatec Holdings, Inc. | -0.0348 |
| AtriCure, Inc. | 0.0816 |
| Baxter International, Inc. | 0.5654 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 321.00M |
| Revenue (Quarterly) | 7.856B |
| Total Expenses (Quarterly) | 7.658B |
| Enterprise Value | 51.32B |
| Gross Profit Margin (Quarterly) | 22.26% |
| Profit Margin (Quarterly) | 4.09% |
| Earnings Yield | 1.71% |
| Operating Earnings Yield | 5.31% |
| Normalized Earnings Yield | 3.117 |